← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2014Last known activity
Aug 11, 2023
Timeline
2010s
- Jun 1, 2014
Catawba Clinical Research— Founded
Drugs by trial phase (15 distinct, 28 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Recent trials (29)
- NCT06673654OfficialPhase 1Aug 11, 2023
- NCT05282771Study directorEarly Phase 1Apr 16, 2021
- NCT04883593Study directorEarly Phase 1Sep 3, 2020
- NCT04883736Study directorEarly Phase 1Aug 31, 2020
- NCT04797793Study directorEarly Phase 1May 18, 2020
- NCT04724473Study directorEarly Phase 1Dec 10, 2019
- NCT04106726CollaboratorPhase 3Oct 11, 2019
- NCT04015375Study chairPhase 3Jul 31, 2019
- NCT04015375CollaboratorPhase 3Jul 31, 2019
- NCT03650361CollaboratorPhase 3Oct 1, 2018
- NCT03522441CollaboratorPhase 3Apr 27, 2018
- NCT03645499Study directorPhase 2Apr 4, 2018
- NCT03427554Study directorEarly Phase 1Aug 21, 2017
- NCT03122353Study directorPhase 1Apr 11, 2017
- NCT03257943Study chairPhase 1Mar 20, 2017
Details
- Founded
- Charlotte, NC, US Jun 1, 2014
- Last known activity
- Aug 11, 2023
Notes
CRO